UCB Frustrated By FDA Failure To Inspect Facility For Psoriasis Drug

Delays Expected Approval Of Bimekizumab

 
• By Kevin Grogan
travel disrupt
COVID-19 travel restrictions prevented inspection of UCB facility • Source: Alamy

More from New Products

More from Scrip